Cboe UK • CHF Cosmo Pharmaceuticals N.V. (COPNZ.XC) Follow Compare 64.20 -0.60 (-0.93%) At close: January 10 at 4:19:31 PM GMT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for COPNZ.XC 1D 5D 0.00% 1M 5.94% 3M -14.06% 6M -9.96% YTD 1.18% 1Y 7.54% 5Y -13.48% All 125.26% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: COPNZ.XC View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates Cosmo Pharmaceuticals Appoints Chief Strategy Officer Cosmo Shareholders Approved Board Proposal to Appoint New Independent Auditor at Today's EGM Cosmo Pharmaceuticals Appoints New Chief Financial Officer Cosmo Pharmaceuticals NV (CMOPF) (H1 2024) Earnings Call Highlights: Revenue Surge and ... Cosmo Pharmaceuticals Enhances Management Team with Newly Appointed Head of Global Business Development Cosmo Pharmaceuticals Highlights Study Published in "The Lancet" Demonstrating the Efficacy of GI Genius(TM) in Colonoscopy Procedures Cosmo Intelligent Medical Devices Unveils Next Generation GI Genius(TM) Hardware with New FDA Clearance Cosmo Achieves Robust Financial Performance in H1 2024 and Confirms Its Full Year Guidance Invitation to Cosmo's Half-Year 2024 Webcast on 24 July 2024 Cosmo Shareholders Approved All Resolutions Proposed by the Board of Directors at Extraordinary General Meeting